Maitsed OÜRegistered
Annual report for 2025 not filed.
Key figures
322 697 €−23,2%
Revenue 2025
+10,9%
Average annual growth 2019–2025
Ratios
202413,7%
Profit margin
14,7%
EBITDA margin
67,7%
Equity ratio
2,7×
Current ratio
75,8%
Return on equity
1867 €
Average gross salary
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 106 220 € | 4 | 11 649 € |
| Q1 2026 | 89 913 € | 6 | 10 642 € |
| Q4 2025 | 101 468 € | 7 | 10 916 € |
| Q3 2025 | 34 350 € | 7 | 10 024 € |
| Q2 2025 | 100 666 € | 5 | 14 428 € |
| Q1 2025 | 90 669 € | 7 | 16 334 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Dividends
calculated2024
Distributed as dividends 15 382 € (49% of distributable profit).
History
202415 382 €
202318 180 €
202214 200 €
20210 €
20200 €
Previous year's retained earnings + previous year's profit − current retained earnings.
Summary of financial statements2019–2024
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Balance sheet — assets | ||||||
| Total current assets | 26 128 | 33 907 | 52 958 | 59 857 | 56 774 | 98 403 |
| Total non-current assets | 18 212 | 11 424 | 10 133 | 6494 | 9041 | 13 654 |
| Total assets | 44 340 | 45 331 | 63 091 | 66 351 | 65 815 | 112 057 |
| Balance sheet — liabilities and equity | ||||||
| Current liabilities | 18 493 | 15 967 | 18 222 | 23 843 | 32 089 | 36 140 |
| Non-current liabilities | 15 742 | 13 290 | 7073 | 1372 | 0 | 0 |
| Total liabilities | 34 235 | 29 257 | 25 295 | 25 215 | 32 089 | 36 140 |
| Share capital | 2500 | 2500 | 2500 | 2500 | 2500 | 2500 |
| Retained earnings of previous periods | 18 764 | 8431 | 13 573 | 21 096 | 20 456 | 15 844 |
| Profit for the year | −11 159 | 5143 | 21 723 | 17 540 | 10 770 | 57 573 |
| Total equity | 10 105 | 16 074 | 37 796 | 41 136 | 33 726 | 75 917 |
| Income statement | ||||||
| Sales revenue | 173 375 | 112 995 | 169 367 | 252 644 | 343 219 | 419 969 |
| Operating profit | −8635 | 7537 | 23 265 | 18 588 | 11 388 | 57 945 |
| EBITDA | — | 12 434 | 27 440 | 22 728 | 15 517 | 61 823 |
| Profit before income tax | −11 159 | 5143 | 21 723 | 17 540 | 10 770 | 57 573 |
| Profit for the reporting year | −11 159 | 5143 | 21 723 | 17 540 | 10 770 | 57 573 |
| Labour costs | 77 856 | 40 864 | 60 220 | 80 524 | 98 258 | 129 979 |
| Depreciation of non-current assets | — | 4897 | 4175 | 4140 | 4129 | 3878 |
| Other indicators | ||||||
| Employees | 3 | 3 | 3 | 4 | 5 | 7 |
| Calculated dividend | — | 0 | 0 | 14 200 | 18 180 | 15 382 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
CompanyPersonShareholderOther roleAdditional link
Annual reportsPDF, XBRL
Loading list of reports…
Source: e-Business Register (RIK). Files open/download directly from the official register.
Related companies
Same activity — Lepinguline toitlustusteenus jm toitlustamine